Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cerebrovascular Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cerebrovascular Diseasemarket, defines the market attractiveness level of Cerebrovascular Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cerebrovascular Disease industry, describes the types of Cerebrovascular Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cerebrovascular Disease market and the development prospects and opportunities of Cerebrovascular Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cerebrovascular Disease market in Chapter 13.
By Player:
Amgen
GlaxoSmithKline
Johnson & Johnson
Merck
Aldagen
Sangamo BioSciences
Sanofi-Aventis
By Type:
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
By End-User:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cerebrovascular Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cerebrovascular Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cerebrovascular Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cerebrovascular Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cerebrovascular Disease Market Analysis and Outlook to 2022
-
7.1 Global Cerebrovascular Disease Consumption (2017-2022)
-
7.2 United States Cerebrovascular Disease Consumption (2017-2022)
-
7.3 Europe Cerebrovascular Disease Consumption (2017-2022)
-
7.4 China Cerebrovascular Disease Consumption (2017-2022)
-
7.5 Japan Cerebrovascular Disease Consumption (2017-2022)
-
7.6 India Cerebrovascular Disease Consumption (2017-2022)
-
7.7 South Korea Cerebrovascular Disease Consumption (2017-2022)
8 Region and Country-wise Cerebrovascular Disease Market Analysis and Outlook to 2028
-
8.1 Global Cerebrovascular Disease Consumption Forecast (2022-2028)
-
8.2 United States Cerebrovascular Disease Consumption Forecast (2022-2028)
-
8.3 Europe Cerebrovascular Disease Consumption Forecast (2022-2028)
-
8.4 China Cerebrovascular Disease Consumption Forecast (2022-2028)
-
8.5 Japan Cerebrovascular Disease Consumption Forecast (2022-2028)
-
8.6 India Cerebrovascular Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Cerebrovascular Disease Consumption Forecast (2022-2028)
9 Global Cerebrovascular Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Cerebrovascular Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Carotid Endarterectomy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Carotid Angioplasty Or Carotid Artery Stenting Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Consumption and Growth Rate (2017-2022)
-
9.2 Global Cerebrovascular Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Academic & Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospitals & Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Contract Research Organizations Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cerebrovascular Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Cerebrovascular Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Carotid Endarterectomy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Carotid Angioplasty Or Carotid Artery Stenting Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cerebrovascular Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Academic & Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospitals & Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Contract Research Organizations Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cerebrovascular Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cerebrovascular Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cerebrovascular Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cerebrovascular Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cerebrovascular Disease Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Cerebrovascular Disease Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Cerebrovascular Disease Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson Cerebrovascular Disease Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Cerebrovascular Disease Product and Service
-
14.5 Aldagen
-
14.5.1 Aldagen Company Details
-
14.5.2 Aldagen Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aldagen Cerebrovascular Disease Product and Service
-
14.6 Sangamo BioSciences
-
14.6.1 Sangamo BioSciences Company Details
-
14.6.2 Sangamo BioSciences Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sangamo BioSciences Cerebrovascular Disease Product and Service
-
14.7 Sanofi-Aventis
-
14.7.1 Sanofi-Aventis Company Details
-
14.7.2 Sanofi-Aventis Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi-Aventis Cerebrovascular Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cerebrovascular Disease
-
Figure Cerebrovascular Disease Picture
-
Table Global Cerebrovascular Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cerebrovascular Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cerebrovascular Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cerebrovascular Disease Consumption by Country (2017-2022)
-
Figure United States Cerebrovascular Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Cerebrovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure China Cerebrovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Cerebrovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure India Cerebrovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cerebrovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cerebrovascular Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carotid Endarterectomy Consumption and Growth Rate (2017-2022)
-
Figure Global Carotid Angioplasty Or Carotid Artery Stenting Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Consumption and Growth Rate (2017-2022)
-
Figure Global Academic & Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals & Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Contract Research Organizations Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Carotid Endarterectomy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carotid Angioplasty Or Carotid Artery Stenting Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic & Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals & Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Contract Research Organizations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cerebrovascular Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cerebrovascular Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cerebrovascular Disease Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Cerebrovascular Disease Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cerebrovascular Disease Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cerebrovascular Disease Product and Service
-
Table Aldagen (Foundation Year, Company Profile and etc.)
-
Table Aldagen Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aldagen Cerebrovascular Disease Product and Service
-
Table Sangamo BioSciences (Foundation Year, Company Profile and etc.)
-
Table Sangamo BioSciences Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo BioSciences Cerebrovascular Disease Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Cerebrovascular Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Cerebrovascular Disease Product and Service
-
